TLPH (Talphera) EBIT per Share: $-0.34 (TTM As of Mar. 2026)

What is Talphera EBIT per Share?

Talphera TLPH -1.46% 34 EBIT per Share is $-0.34 as of Mar. 2026. GuruFocus rates TLPH with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 810 Drug Manufacturers companies, Talphera ranks better than 89.01% on this metric.

Talphera's EBIT per Share for the three months ended in Mar. 2026 was $-0.06. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.34.

During the past 3 years, the average EBIT per Share Growth Rate was 51.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 50.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 31.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Talphera's EBIT per Share or its related term are showing as below:

TLPH' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -61.4 Med: 31.5 Max: 67.1
Current: 51.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Talphera was 67.10% per year. The lowest was -61.40% per year. And the median was 31.50% per year.

TLPH's 3-Year EBIT Growth Rate is ranked better than
89.01% of 810 companies
in the Drug Manufacturers industry
Industry Median: 7.65 vs TLPH: 51.30

Talphera's EBIT for the three months ended in Mar. 2026 was $-3.95 Mil.

Talphera (NAS:TLPH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Talphera EBIT per Share Related Terms

Talphera EBIT per Share Historical Data

* Premium members only.

The historical data trend for Talphera's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talphera EBIT per Share Chart

Talphera Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT per Share

Get a 7-Day Free Trial

-5.47

8.14

-0.71

-0.49

-0.34

Talphera Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT per Share	Get a 7-Day Free Trial															-0.11	-0.10	-0.11	-0.08	-0.06

34GF Score

Talphera Inc TLPH

EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Talphera EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Talphera's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

	EBIT per Share		(A: Dec. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-14.363	/	42.411
=	-0.34

Talphera's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

	EBIT per Share		(Q: Mar. 2026 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.948	/	69.822
=	-0.06

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34

Frequently Asked Questions Learn more about EBIT per Share →

What does a EBIT per Share of $-0.34 mean?

Talphera (TLPH) has a EBIT per Share of $-0.34 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Talphera and its competitors. According to the industry distribution chart, Talphera ranks #89 out of 810 companies in the Drug Manufacturers industry, placing it in the top 11%.

Is Talphera's EBIT per Share too high?

Talphera's current EBIT per Share is $-0.34. Based on the distribution chart, Talphera ranks #89 out of 810 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Talphera has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.

How does Talphera's EBIT per Share compare to CTOR and ETST?

According to the Drug Manufacturers industry distribution chart, Talphera ranks #89 out of 810 companies for EBIT per Share. This places Talphera in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 7.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT per Share for a Drug Manufacturers company?

The median EBIT per Share among Drug Manufacturers companies is 7.65, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT per Share mean?

A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Talphera and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Talphera's current EBIT per Share is $-0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Talphera stock overvalued right now?

Talphera (TLPH) has a current EBIT per Share of $-0.34. The current EBIT per Share is $-0.34. Talphera's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT per Share calculated?

EBIT per Share is calculated from a company's financial statements. For Talphera (TLPH), the current EBIT per Share is $-0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talphera Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies CTOR ETST INCR IXHL BTAI SCYX INIS ZYBT HYEX MRMD XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges R5XA:Germany

Address 1850 Gateway Drive, Suite 175, San Mateo, CA, USA, 94404

Website https://www.talphera.com

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

34GF Score

Get the complete analysis for TLPH

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.02

Price

View TLPH Analysis

See EBIT per Share data for all stocks →